Takeda Pharmaceutical (TAK) EPS (Basic) Growth (5y) (2022 - 2026)
Takeda Pharmaceutical (TAK) EPS (Basic) Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.11 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.27 Bn | 39.61 Bn | 2.15 Bn |
| 3 | Zoetis | 31.81 Bn | 30.14 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.91% |
| Mar 31, 2026 | -15.86% |
| Dec 31, 2025 | -36.25% |
| Sep 30, 2025 | 107.41% |
| Jun 30, 2025 | 2.02% |
| Mar 31, 2025 | 119.29% |
| Sep 30, 2024 | 17.26% |
| Jun 30, 2024 | -60.56% |
| Mar 31, 2024 | 28.37% |
| Dec 31, 2023 | -20.67% |
| Sep 30, 2023 | 7,342.66% |
| Jun 30, 2023 | -14.49% |
| Mar 31, 2023 | 17.55% |
| Dec 31, 2022 | -12.59% |